Ache

Annual Report 2013

Introduction

Strategic and competitive management consolidates sustainable growth

Destaques de 2013



Profile

With net revenues of R$ 1.86 billion in 2013 and 16.1% growth from the prior year, the company is among the largest pharmaceutical companies operating in Brazil.

Destaques de 2013

Governance

The Board is supported by collegiate Committees of strategy, people, finance and corporate risk management to take decisions about the directives received from the Board of Directors.

Destaques de 2013

Management

The Company looks for opportunities, identifies and anticipates trends to build the platform of growth.

Destaques de 2013

Innovation

In 2013, 32 products were launched. This is a high number considering the market, and it shows that Aché developed the knowledge for the constant renewal of its portfolio and is capable of maintaining the leadership with new offers every year.

Destaques de 2013

Performance

Capillarity of medical detailing, presence in points of sale and frequency of product launches add value to the business.

Destaques de 2013

Relationship

Programs of continuing medical education, accreditation of suppliers and channels of communication with consumers and relationship with communities promote dialogue with Aché´s stakeholders.

Destaques de 2013